The gain-of-function of PRMT5 in cardiomyocytes accelerates pressure overload-induced cardiac hypertrophy and left ventricular systolic dysfunction through the regulation of p300 HAT activity. The gene discussed is EP300; the disease is cardiac hypertrophy.